| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | NUGGC RRAGB RHOU ABCB4 IFIH1 RHOV DDX60L ABCC2 GNG5 DNAH5 DNAH9 RAP1A RAP1B RNF213 ATP10A DNAH7 KIF20B FBH1 RRAGA ENTPD1 ABCC12 FIGNL1 | 4.29e-05 | 775 | 218 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | NUGGC RRAGB RHOU ABCB4 IFIH1 RHOV DDX60L ABCC2 GNG5 DNAH5 DNAH9 RAP1A RAP1B RNF213 ATP10A DNAH7 KIF20B FBH1 RRAGA ENTPD1 ABCC12 FIGNL1 | 1.36e-04 | 839 | 218 | 22 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | NUGGC RRAGB RHOU ABCB4 IFIH1 RHOV DDX60L ABCC2 GNG5 DNAH5 DNAH9 RAP1A RAP1B RNF213 ATP10A DNAH7 KIF20B FBH1 RRAGA ENTPD1 ABCC12 FIGNL1 | 1.38e-04 | 840 | 218 | 22 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | NUGGC RRAGB RHOU ABCB4 IFIH1 RHOV DDX60L ABCC2 GNG5 DNAH5 DNAH9 RAP1A RAP1B RNF213 ATP10A DNAH7 KIF20B FBH1 RRAGA ENTPD1 ABCC12 FIGNL1 | 1.38e-04 | 840 | 218 | 22 | GO:0016818 |
| GeneOntologyMolecularFunction | JUN kinase activity | 3.53e-04 | 3 | 218 | 2 | GO:0004705 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCB4 IFIH1 DDX60L ABCC2 DNAH5 DNAH9 RNF213 ATP10A DNAH7 KIF20B FBH1 ENTPD1 ABCC12 FIGNL1 | 3.68e-04 | 441 | 218 | 14 | GO:0016887 |
| GeneOntologyCellularComponent | cytoplasmic region | BAIAP2 DNAH5 DNAH9 IQUB BRWD1 UNC13B ARFGEF2 ODAD2 DNAH7 WDPCP CTNNB1 MAPK8 MAP2K1 UNC13A CFAP46 | 7.26e-06 | 360 | 221 | 15 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | BAIAP2 DNAH5 DNAH9 IQUB BRWD1 ARFGEF2 ODAD2 DNAH7 WDPCP MAPK8 MAP2K1 CFAP46 | 1.50e-04 | 317 | 221 | 12 | GO:0032838 |
| GeneOntologyCellularComponent | RAVE complex | 3.31e-04 | 3 | 221 | 2 | GO:0043291 | |
| GeneOntologyCellularComponent | axoneme | 3.71e-04 | 207 | 221 | 9 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 3.85e-04 | 208 | 221 | 9 | GO:0097014 | |
| Domain | ARM-type_fold | RALGAPA1 DOCK11 NCBP1 AP1G1 RPTOR DIAPH2 UTP20 KPNA1 DOCK9 UBR4 ARFGEF2 ODAD2 HUWE1 PPP4R3A INF2 MTOR WDFY3 CTNNB1 | 1.02e-07 | 339 | 218 | 18 | IPR016024 |
| Domain | P-loop_NTPase | NUGGC RRAGB DCK RHOU ABCB4 IFIH1 SAMD9L NOD1 TRANK1 RHOV DDX60L ABCC2 DNAH5 DNAH9 KIF11 RAP1A RAP1B RNF213 MSH3 DNAH7 KIF20B FBH1 RRAGA N4BP2 ABCC12 FIGNL1 | 6.86e-06 | 848 | 218 | 26 | IPR027417 |
| Domain | - | NUGGC RRAGB DCK RHOU ABCB4 IFIH1 SAMD9L NOD1 TRANK1 RHOV DDX60L ABCC2 DNAH5 DNAH9 RAP1A RAP1B RNF213 MSH3 DNAH7 FBH1 RRAGA N4BP2 ABCC12 FIGNL1 | 7.17e-06 | 746 | 218 | 24 | 3.40.50.300 |
| Domain | BTB | 1.12e-04 | 160 | 218 | 9 | PS50097 | |
| Domain | DUF1712 | 1.36e-04 | 2 | 218 | 2 | PF08217 | |
| Domain | DNA_helicase_UvrD/REP | 1.36e-04 | 2 | 218 | 2 | IPR000212 | |
| Domain | DUF1712_fun | 1.36e-04 | 2 | 218 | 2 | IPR013176 | |
| Domain | BTB | 2.72e-04 | 180 | 218 | 9 | SM00225 | |
| Domain | AAA | 2.93e-04 | 144 | 218 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 2.93e-04 | 144 | 218 | 8 | IPR003593 | |
| Domain | CARD | 2.97e-04 | 28 | 218 | 4 | PF00619 | |
| Domain | BTB/POZ_dom | 3.33e-04 | 185 | 218 | 9 | IPR000210 | |
| Domain | ARM-like | AP1G1 RPTOR UTP20 KPNA1 ARFGEF2 ODAD2 HUWE1 PPP4R3A MTOR WDFY3 CTNNB1 | 3.45e-04 | 270 | 218 | 11 | IPR011989 |
| Domain | SKP1/BTB/POZ | 3.89e-04 | 189 | 218 | 9 | IPR011333 | |
| Domain | Unc-13 | 4.04e-04 | 3 | 218 | 2 | IPR027080 | |
| Domain | CARD | 4.44e-04 | 31 | 218 | 4 | IPR001315 | |
| Domain | PH_dom-like | DOCK11 OBSCN FRMD4B PLEKHH1 PTPN4 PLCL2 PLEKHH2 RANBP2 PLEKHG7 DOCK9 PPP4R3A RANBP3L PLEKHA3 WDFY3 | 5.03e-04 | 426 | 218 | 14 | IPR011993 |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-04 | 14 | 218 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.19e-04 | 14 | 218 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.19e-04 | 14 | 218 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.19e-04 | 14 | 218 | 3 | PF08393 | |
| Domain | MT | 5.19e-04 | 14 | 218 | 3 | PF12777 | |
| Domain | AAA_8 | 5.19e-04 | 14 | 218 | 3 | PF12780 | |
| Domain | CARD | 5.67e-04 | 33 | 218 | 4 | PS50209 | |
| Domain | DHC_fam | 6.43e-04 | 15 | 218 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 6.43e-04 | 15 | 218 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.43e-04 | 15 | 218 | 3 | IPR004273 | |
| Domain | - | DOCK11 OBSCN FRMD4B PLEKHH1 PTPN4 PLCL2 PLEKHH2 RANBP2 PLEKHG7 DOCK9 PPP4R3A RANBP3L PLEKHA3 | 7.15e-04 | 391 | 218 | 13 | 2.30.29.30 |
| Domain | OAS1_C | 8.01e-04 | 4 | 218 | 2 | PF10421 | |
| Domain | HJURP_C | 8.01e-04 | 4 | 218 | 2 | IPR022102 | |
| Domain | KASH | 8.01e-04 | 4 | 218 | 2 | IPR012315 | |
| Domain | MADS_MEF2-like | 8.01e-04 | 4 | 218 | 2 | IPR033896 | |
| Domain | KASH | 8.01e-04 | 4 | 218 | 2 | PS51049 | |
| Domain | 2-5-oligoadenylate_synth_CS | 8.01e-04 | 4 | 218 | 2 | IPR006117 | |
| Domain | 25A_SYNTH_3 | 8.01e-04 | 4 | 218 | 2 | PS50152 | |
| Domain | Gtr1_RagA | 8.01e-04 | 4 | 218 | 2 | IPR006762 | |
| Domain | 2-5-oligoAdlate_synth_1_dom2/C | 8.01e-04 | 4 | 218 | 2 | IPR018952 | |
| Domain | KASH | 8.01e-04 | 4 | 218 | 2 | SM01249 | |
| Domain | 2-5A_synthase | 8.01e-04 | 4 | 218 | 2 | IPR026774 | |
| Domain | KASH | 8.01e-04 | 4 | 218 | 2 | PF10541 | |
| Domain | - | 8.01e-04 | 4 | 218 | 2 | 1.10.1410.20 | |
| Domain | 25A_SYNTH_1 | 8.01e-04 | 4 | 218 | 2 | PS00832 | |
| Domain | 25A_SYNTH_2 | 8.01e-04 | 4 | 218 | 2 | PS00833 | |
| Domain | HJURP_C | 8.01e-04 | 4 | 218 | 2 | PF12347 | |
| Domain | Gtr1_RagA | 8.01e-04 | 4 | 218 | 2 | PF04670 | |
| Domain | BTB | 8.81e-04 | 131 | 218 | 7 | PF00651 | |
| Domain | - | 1.23e-03 | 222 | 218 | 9 | 1.25.10.10 | |
| Domain | Munc13_dom-2 | 1.33e-03 | 5 | 218 | 2 | IPR014772 | |
| Domain | MHD2 | 1.33e-03 | 5 | 218 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 1.33e-03 | 5 | 218 | 2 | IPR019558 | |
| Domain | 2-5-oligoadenylate_synth_N | 1.33e-03 | 5 | 218 | 2 | IPR006116 | |
| Domain | Membr_traf_MHD | 1.33e-03 | 5 | 218 | 2 | PF10540 | |
| Domain | MAPK_JNK | 1.33e-03 | 5 | 218 | 2 | IPR008351 | |
| Domain | DUF1041 | 1.33e-03 | 5 | 218 | 2 | SM01145 | |
| Domain | MADS_BOX_1 | 1.97e-03 | 6 | 218 | 2 | PS00350 | |
| Domain | DUF3398 | 1.97e-03 | 6 | 218 | 2 | PF11878 | |
| Domain | MADS | 1.97e-03 | 6 | 218 | 2 | SM00432 | |
| Domain | SRF-TF | 1.97e-03 | 6 | 218 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 1.97e-03 | 6 | 218 | 2 | PS50066 | |
| Domain | DOCK_C/D_N | 1.97e-03 | 6 | 218 | 2 | IPR021816 | |
| Domain | FERM_M | 2.01e-03 | 46 | 218 | 4 | PF00373 | |
| Domain | - | 2.54e-03 | 49 | 218 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 2.54e-03 | 49 | 218 | 4 | IPR019748 | |
| Domain | FERM_domain | 2.54e-03 | 49 | 218 | 4 | IPR000299 | |
| Domain | ABC_membrane | 2.65e-03 | 24 | 218 | 3 | PF00664 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.73e-03 | 50 | 218 | 4 | IPR014352 | |
| Domain | FERM_1 | 2.73e-03 | 50 | 218 | 4 | PS00660 | |
| Domain | FERM_2 | 2.73e-03 | 50 | 218 | 4 | PS00661 | |
| Domain | FERM_3 | 2.73e-03 | 50 | 218 | 4 | PS50057 | |
| Domain | Band_41_domain | 2.73e-03 | 50 | 218 | 4 | IPR019749 | |
| Domain | B41 | 2.73e-03 | 50 | 218 | 4 | SM00295 | |
| Domain | Munc13_1 | 2.74e-03 | 7 | 218 | 2 | IPR014770 | |
| Domain | MHD1 | 2.74e-03 | 7 | 218 | 2 | PS51258 | |
| Domain | TF_MADSbox | 2.74e-03 | 7 | 218 | 2 | IPR002100 | |
| Domain | DUF1041 | 2.74e-03 | 7 | 218 | 2 | PF06292 | |
| Domain | CAPS_dom | 2.74e-03 | 7 | 218 | 2 | IPR010439 | |
| Pathway | REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE | 3.84e-06 | 109 | 159 | 9 | M29565 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 1.21e-05 | 46 | 159 | 6 | M39805 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY | 1.43e-05 | 14 | 159 | 4 | M47922 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY | 1.43e-05 | 14 | 159 | 4 | M47918 | |
| Pathway | REACTOME_BACTERIAL_INFECTION_PATHWAYS | 1.48e-05 | 71 | 159 | 7 | M48033 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 1.48e-05 | 71 | 159 | 7 | M27382 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | TRAF2 MEF2A MEF2C PTPN4 NOD1 BIRC2 MAPK8 MAPK9 MAP2K1 MAP2K6 | 2.27e-05 | 170 | 159 | 10 | M7494 |
| Pathway | PID_MET_PATHWAY | 2.99e-05 | 79 | 159 | 7 | M48 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION | 3.15e-05 | 33 | 159 | 5 | M39909 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE | 3.18e-05 | 109 | 159 | 8 | M27012 | |
| Pathway | WP_RANKLRANK_SIGNALING | 3.44e-05 | 55 | 159 | 6 | M39667 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 3.66e-05 | 34 | 159 | 5 | M270 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE | 4.68e-05 | 115 | 159 | 8 | M27013 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY | 4.77e-05 | 7 | 159 | 3 | M47697 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | TRAF2 MEF2A MEF2C RHOU STAT2 FANCC PTPN4 NOD1 KPNA1 BRWD1 RANBP2 RAP1B BIRC2 OAS2 OAS3 CSK IGHG1 MAPK8 MAPK9 MAP2K1 MAP2K6 IL2RG | 7.60e-05 | 789 | 159 | 22 | M1060 |
| Pathway | WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING | 1.04e-04 | 42 | 159 | 5 | M39452 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.06e-04 | 129 | 159 | 8 | M186 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.17e-04 | 23 | 159 | 4 | MM14953 | |
| Pathway | PID_MTOR_4PATHWAY | 1.25e-04 | 69 | 159 | 6 | M121 | |
| Pathway | PID_CDC42_PATHWAY | 1.35e-04 | 70 | 159 | 6 | M81 | |
| Pathway | REACTOME_MTORC1_MEDIATED_SIGNALLING | 1.39e-04 | 24 | 159 | 4 | M3492 | |
| Pathway | REACTOME_MTORC1_MEDIATED_SIGNALLING | 1.64e-04 | 25 | 159 | 4 | MM14650 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.71e-04 | 73 | 159 | 6 | MM15223 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 1.84e-04 | 105 | 159 | 7 | M164 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.92e-04 | 26 | 159 | 4 | M47565 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS | 2.17e-04 | 11 | 159 | 3 | M27420 | |
| Pathway | REACTOME_APOPTOSIS | 2.19e-04 | 108 | 159 | 7 | MM14471 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 2.23e-04 | 27 | 159 | 4 | MM15537 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 2.26e-04 | 144 | 159 | 8 | M39691 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.65e-04 | 51 | 159 | 5 | MM14499 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.65e-04 | 51 | 159 | 5 | M4281 | |
| Pathway | REACTOME_MYOGENESIS | 2.97e-04 | 29 | 159 | 4 | M853 | |
| Pathway | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | 2.97e-04 | 29 | 159 | 4 | M19861 | |
| Pathway | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | 2.97e-04 | 29 | 159 | 4 | MM14980 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | TRAF2 MEF2A MEF2C RHOU STAT2 PTPN4 NOD1 BRWD1 RAP1B IGHG1 MAPK8 MAPK9 MAP2K1 MAP2K6 IL2RG | 2.99e-04 | 473 | 159 | 15 | M874 |
| Pathway | WP_GASTRIN_SIGNALING | 3.22e-04 | 115 | 159 | 7 | M39866 | |
| Pathway | PID_RAC1_PATHWAY | 3.47e-04 | 54 | 159 | 5 | M278 | |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 3.47e-04 | 54 | 159 | 5 | M39435 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 3.69e-04 | 84 | 159 | 6 | M27495 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 3.78e-04 | 55 | 159 | 5 | M39685 | |
| Pathway | REACTOME_AMINO_ACIDS_REGULATE_MTORC1 | 3.78e-04 | 55 | 159 | 5 | M29825 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 3.87e-04 | 31 | 159 | 4 | M15195 | |
| Pathway | PID_CD40_PATHWAY | 3.87e-04 | 31 | 159 | 4 | M45 | |
| Pathway | WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION | 3.87e-04 | 31 | 159 | 4 | M39859 | |
| Pathway | REACTOME_AMINO_ACIDS_REGULATE_MTORC1 | 4.12e-04 | 56 | 159 | 5 | MM15667 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 4.60e-04 | 160 | 159 | 8 | MM15990 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE | 4.61e-04 | 122 | 159 | 7 | MM14640 | |
| Pathway | WP_MAPK_SIGNALING | TRAF2 MEF2C STK4 CACNA1E RAP1A RAP1B MAPK8 MAPK9 MAP2K1 MAP2K6 | 4.79e-04 | 246 | 159 | 10 | M39597 |
| Pathway | BIOCARTA_MET_PATHWAY | 4.94e-04 | 33 | 159 | 4 | M19358 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 4.94e-04 | 33 | 159 | 4 | MM1426 | |
| Pathway | BIOCARTA_MET_PATHWAY | 4.94e-04 | 33 | 159 | 4 | MM1494 | |
| Pathway | WP_EGFEGFR_SIGNALING | 5.00e-04 | 162 | 159 | 8 | M39334 | |
| Pathway | PID_FAK_PATHWAY | 5.25e-04 | 59 | 159 | 5 | M281 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 5.55e-04 | 34 | 159 | 4 | M3342 | |
| Pathway | WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING | 5.55e-04 | 34 | 159 | 4 | M39383 | |
| Pathway | WP_13Q1212_COPY_NUMBER_VARIATION | 5.55e-04 | 34 | 159 | 4 | M48103 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 5.59e-04 | 126 | 159 | 7 | M16763 | |
| Pathway | KEGG_COLORECTAL_CANCER | 6.61e-04 | 62 | 159 | 5 | M14631 | |
| Pathway | WP_TARGET_OF_RAPAMYCIN_SIGNALING | 6.93e-04 | 36 | 159 | 4 | M39635 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 6.93e-04 | 36 | 159 | 4 | M39908 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY | 7.08e-04 | 16 | 159 | 3 | M47569 | |
| Pathway | PID_FAS_PATHWAY | 8.53e-04 | 38 | 159 | 4 | M94 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 8.53e-04 | 38 | 159 | 4 | M27255 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 8.80e-04 | 66 | 159 | 5 | M39684 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 8.80e-04 | 136 | 159 | 7 | M42547 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | TRAF2 MEF2C STK4 CACNA1E RAP1A RAP1B MAPK8 MAPK9 MAP2K1 MAP2K6 | 9.02e-04 | 267 | 159 | 10 | M10792 |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 9.43e-04 | 39 | 159 | 4 | MM15272 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 1.01e-03 | 68 | 159 | 5 | M16848 | |
| Pathway | PID_ANTHRAX_PATHWAY | 1.01e-03 | 18 | 159 | 3 | M267 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.03e-03 | 102 | 159 | 6 | MM15830 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.03e-03 | 102 | 159 | 6 | M39577 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 1.04e-03 | 40 | 159 | 4 | M27557 | |
| Pathway | PID_IFNG_PATHWAY | 1.04e-03 | 40 | 159 | 4 | M161 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | RPL24 NCBP1 STAT2 IFIH1 NOD1 AP1G1 ANTXR1 BAIAP2 GNG5 FKBP4 KPNA1 RANBP2 RNF213 OAS2 TRIM27 YWHAH GTF2H3 IGHG1 ENTPD1 CTNNB1 MAPK8 MAP2K1 MAP2K6 PTGES3 | 1.05e-03 | 1081 | 159 | 24 | M27548 |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.13e-03 | 142 | 159 | 7 | MM15178 | |
| Pathway | REACTOME_MTOR_SIGNALLING | 1.14e-03 | 41 | 159 | 4 | M27000 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY | 1.24e-03 | 5 | 159 | 2 | M49021 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY | 1.24e-03 | 5 | 159 | 2 | M49005 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY | 1.24e-03 | 5 | 159 | 2 | M47570 | |
| Pathway | REACTOME_MTOR_SIGNALLING | 1.25e-03 | 42 | 159 | 4 | MM14638 | |
| Pathway | WP_FOCAL_ADHESION | 1.27e-03 | 187 | 159 | 8 | MM15913 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 1.39e-03 | 73 | 159 | 5 | M39758 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 1.49e-03 | 44 | 159 | 4 | M175 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 1.53e-03 | 110 | 159 | 6 | M48043 | |
| Pathway | BIOCARTA_CERAMIDE_PATHWAY | 1.61e-03 | 21 | 159 | 3 | M19943 | |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 1.61e-03 | 21 | 159 | 3 | M48342 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 1.62e-03 | 45 | 159 | 4 | M27623 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.66e-03 | 76 | 159 | 5 | MM1433 | |
| Pathway | WP_16P112_PROXIMAL_DELETION_SYNDROME | 1.66e-03 | 76 | 159 | 5 | M40057 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.76e-03 | 46 | 159 | 4 | M19118 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.76e-03 | 46 | 159 | 4 | MM1428 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY | 1.84e-03 | 6 | 159 | 2 | M47680 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY | 1.84e-03 | 6 | 159 | 2 | M47698 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY | 1.84e-03 | 6 | 159 | 2 | M47712 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.84e-03 | 6 | 159 | 2 | M47636 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.85e-03 | 22 | 159 | 3 | M7747 | |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 1.85e-03 | 22 | 159 | 3 | M859 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 1.87e-03 | 78 | 159 | 5 | M39824 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 1.88e-03 | 155 | 159 | 7 | MM14665 | |
| Pathway | WP_FOCAL_ADHESION | 1.89e-03 | 199 | 159 | 8 | M39402 | |
| Pubmed | TRAF2 BACH1 NCBP1 ZNF302 FRMD4B PLEKHH1 ODF2L SACS GLS DLAT BAIAP2 SMURF2 DOP1B KPNA1 BRWD1 UNC13B DSP SYNE1 UBR4 ARFGEF2 BIRC2 MSH3 HUWE1 YWHAH FRY FBH1 EXOC1 WDFY3 PTGES3 PCM1 | 1.11e-09 | 1285 | 223 | 30 | 35914814 | |
| Pubmed | 1.28e-09 | 9 | 223 | 5 | 24337580 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 DOCK11 MATK BACH1 SH3BP4 STK4 FSIP2 RPTOR SYNE2 BAIAP2 TRAPPC9 KIF11 DOP1B DSP DNAH7 YWHAH VPS13D MTOR N4BP2 PLEKHA3 CNKSR3 NEURL1 MAP2K1 PCM1 | 2.01e-09 | 861 | 223 | 24 | 36931259 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL24 TRAF2 SETD1B U2AF2 DCK STK4 AP1G1 RBM19 RPTOR GLS DLAT UTP20 DDX60L KIF11 KPNA1 RANBP2 DSP UBR4 THUMPD3 RPP38 BAZ1B OAS3 MSH3 HUWE1 KIF20B INF2 IGHG1 EXOC1 WDFY3 | 1.43e-08 | 1353 | 223 | 29 | 29467282 |
| Pubmed | The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. | 2.44e-08 | 6 | 223 | 4 | 18497260 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1B OBSCN SH3BP4 RGMA HEG1 RBM19 RPTOR DIAPH2 MICAL3 SMURF2 TRAPPC9 UNC13B DOCK9 UBE3B UBR4 SLC35B3 ARFGEF2 HUWE1 NBPF1 PIKFYVE CPTP GET4 INF2 MTOR WDFY3 | 5.55e-08 | 1105 | 223 | 25 | 35748872 |
| Pubmed | RALGAPA1 SLC35E1 FRMD4B STAT2 STK4 TMTC3 BAIAP2 TASOR CCZ1B ICE2 SLC43A1 VPS50 RNF213 HUWE1 PIKFYVE IBTK VANGL1 N4BP2 CTNNB1 PCM1 | 6.73e-08 | 733 | 223 | 20 | 34672954 | |
| Pubmed | DOCK11 EPM2AIP1 RPTOR SYNE2 DIAPH2 BAIAP2 KIF11 KPNA1 CACNA1E RANBP2 RAP1A SYNE1 UBR4 HUWE1 YWHAH FRY MTOR N4BP2 CNKSR3 WDFY3 CTNNB1 UNC13A PCM1 | 7.49e-08 | 963 | 223 | 23 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 KBTBD3 PTDSS1 OBSCN U2AF2 MEF2A SH3BP4 PLEKHH1 KLHL29 PTPN4 ODF2L UBE2J2 RPTOR ANTXR1 MICAL3 BAIAP2 SMURF2 TRAPPC9 KPNA1 RAP1A RNF213 HUWE1 ATP10A HPS3 NBPF1 ZBTB46 INF2 ENTPD1 PCM1 | 1.11e-07 | 1489 | 223 | 29 | 28611215 |
| Pubmed | RALGAPA1 SLC35E1 DMXL1 SH3BP4 RPTOR SYNE2 DIAPH2 DOP1B CCZ1B ARFGEF2 HPS3 PIKFYVE VPS13D INF2 VANGL1 RRAGA | 1.97e-07 | 504 | 223 | 16 | 34432599 | |
| Pubmed | U2AF2 NCBP1 HMGCL ABCB4 SACS SYNE2 GLS PKHD1 CC2D2A ANTXR1 DLAT ABCC2 TASOR SMURF2 KIF11 CACNA1E RANBP2 RAP1A RAP1B DSP PCDHGA6 SYNE1 UBR4 RNF17 YWHAH N4BP2 CNKSR3 CFAP46 | 2.00e-07 | 1442 | 223 | 28 | 35575683 | |
| Pubmed | p62 is a key regulator of nutrient sensing in the mTORC1 pathway. | 2.02e-07 | 9 | 223 | 4 | 21981924 | |
| Pubmed | Metabolism. Differential regulation of mTORC1 by leucine and glutamine. | 2.60e-07 | 3 | 223 | 3 | 25567907 | |
| Pubmed | JNK phosphorylates beta-catenin and regulates adherens junctions. | 2.60e-07 | 3 | 223 | 3 | 19667122 | |
| Pubmed | Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. | 3.35e-07 | 10 | 223 | 4 | 22424946 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | U2AF2 ATRIP AP1G1 DLAT UTP20 BAIAP2 KPNA1 RAP1B RPP38 OAS3 KIF20B IGHG1 USP39 CTNNB1 | 4.92e-07 | 410 | 223 | 14 | 26949251 |
| Pubmed | 5.07e-07 | 74 | 223 | 7 | 15276183 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RPL24 SETD1B DOCK11 MEF2C DMXL1 TRAPPC9 CACNA1E RANBP2 DSP UBR4 BTBD10 YWHAH FRY USP39 PCM1 | 5.12e-07 | 475 | 223 | 15 | 31040226 |
| Pubmed | 5.24e-07 | 11 | 223 | 4 | 19622544 | ||
| Pubmed | Reprogramming tumour-associated macrophages to outcompete cancer cells. | 5.24e-07 | 11 | 223 | 4 | 37380769 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL24 TRAF2 U2AF2 NCBP1 HMGCL AP1G1 RBM19 RPTOR GLS CC2D2A DLAT UTP20 DNAH5 FKBP4 KIF11 RANBP2 RAP1B DSP SYNE1 UBR4 THUMPD3 BAZ1B MSH3 HUWE1 MTOR USP39 PTGES3 | 5.41e-07 | 1425 | 223 | 27 | 30948266 |
| Pubmed | 7.82e-07 | 12 | 223 | 4 | 28641113 | ||
| Pubmed | SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. | 7.82e-07 | 12 | 223 | 4 | 25561175 | |
| Pubmed | 7.82e-07 | 12 | 223 | 4 | 20381137 | ||
| Pubmed | 1.04e-06 | 4 | 223 | 3 | 27188501 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETD1B STAT2 ODF2L RPTOR DSP VPS50 BAZ1B HUWE1 KIF20B PPP4R3A PIKFYVE N4BP2 CTNNB1 MAPK9 ZMYM6 PCM1 | 1.50e-06 | 588 | 223 | 16 | 38580884 |
| Pubmed | MEK kinase 1 regulates c-Jun phosphorylation in the control of corneal morphogenesis. | 1.57e-06 | 14 | 223 | 4 | 14627958 | |
| Pubmed | TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer. | 1.57e-06 | 14 | 223 | 4 | 28716898 | |
| Pubmed | 1.79e-06 | 89 | 223 | 7 | 18950845 | ||
| Pubmed | RPL24 TRAF2 PPP2R3B HMGCL BAIAP2 CCZ1B UBR4 BIRC2 RNF213 HUWE1 TRIM27 MTERF4 GTF2H3 VANGL1 CTNNB1 NXPH3 | 2.12e-06 | 604 | 223 | 16 | 38803224 | |
| Pubmed | 2.12e-06 | 15 | 223 | 4 | 11597177 | ||
| Pubmed | DOCK11 LRCH1 STK4 FKBP4 BRWD1 RANBP2 DSP UBR4 RPP38 HUWE1 INF2 VANGL1 CTNNB1 | 2.13e-06 | 399 | 223 | 13 | 37536630 | |
| Pubmed | 2.58e-06 | 5 | 223 | 3 | 29153991 | ||
| Pubmed | HSF1 critically attunes proteotoxic stress sensing by mTORC1 to combat stress and promote growth. | 2.58e-06 | 5 | 223 | 3 | 27043084 | |
| Pubmed | 2.58e-06 | 5 | 223 | 3 | 15861135 | ||
| Pubmed | 2.58e-06 | 5 | 223 | 3 | 21541287 | ||
| Pubmed | 2.58e-06 | 5 | 223 | 3 | 22493283 | ||
| Pubmed | ARMC4 mutations cause primary ciliary dyskinesia with randomization of left/right body asymmetry. | 2.58e-06 | 5 | 223 | 3 | 23849778 | |
| Pubmed | SH3BP4 is a negative regulator of amino acid-Rag GTPase-mTORC1 signaling. | 2.58e-06 | 5 | 223 | 3 | 22575674 | |
| Pubmed | DSP UBR4 VPS50 ARFGEF2 HUWE1 YWHAH GET4 CSK INF2 MTOR MAP2K1 | 2.91e-06 | 288 | 223 | 11 | 23383273 | |
| Pubmed | PTDSS1 SAMD9L SACS GLS MICAL3 PLEKHH2 TASOR TRAPPC9 RNF213 ATP10A PPP4R3A PIKFYVE VPS13D N4BP2 | 4.23e-06 | 493 | 223 | 14 | 15368895 | |
| Pubmed | 4.47e-06 | 102 | 223 | 7 | 10231032 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NUGGC DOCK11 BACH1 OBSCN IFIH1 TRANK1 DIAPH2 MICAL3 RMND1 GPR37 DOCK9 VPS50 VPS13D USP39 | 4.64e-06 | 497 | 223 | 14 | 36774506 |
| Pubmed | Architecture of human Rag GTPase heterodimers and their complex with mTORC1. | 5.13e-06 | 6 | 223 | 3 | 31601764 | |
| Pubmed | 5.13e-06 | 6 | 223 | 3 | 26180201 | ||
| Pubmed | 5.13e-06 | 6 | 223 | 3 | 28137909 | ||
| Pubmed | 5.13e-06 | 6 | 223 | 3 | 18842593 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PPP2R3B LIN7A PTPN4 TMTC3 RMND1 KIF11 KPNA1 RANBP2 UBR4 HUWE1 YWHAH PPP4R3A GET4 CSK MTOR VANGL1 MAPK8 MAPK9 PTGES3 PCM1 | 5.45e-06 | 974 | 223 | 20 | 28675297 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DOCK11 OBSCN NCBP1 SAMD9L PKHD1 UTP20 DOP1B DSP GPR37 UBR4 RNF213 HUWE1 FRY RANBP3L USP39 MAPK9 CXCR2 | 6.27e-06 | 736 | 223 | 17 | 29676528 |
| Pubmed | 7.02e-06 | 153 | 223 | 8 | 10718198 | ||
| Pubmed | 8.93e-06 | 7 | 223 | 3 | 18316368 | ||
| Pubmed | JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. | 8.93e-06 | 7 | 223 | 3 | 22753496 | |
| Pubmed | NLK phosphorylates Raptor to mediate stress-induced mTORC1 inhibition. | 8.93e-06 | 7 | 223 | 3 | 26588989 | |
| Pubmed | Baicalein modulates Nrf2/Keap1 system in both Keap1-dependent and Keap1-independent mechanisms. | 8.93e-06 | 7 | 223 | 3 | 24704364 | |
| Pubmed | 8.93e-06 | 7 | 223 | 3 | 33157014 | ||
| Pubmed | TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. | 8.93e-06 | 7 | 223 | 3 | 28489822 | |
| Pubmed | 8.93e-06 | 7 | 223 | 3 | 11062067 | ||
| Pubmed | Arginine methylation-dependent regulation of ASK1 signaling by PRMT1. | 8.93e-06 | 7 | 223 | 3 | 22095282 | |
| Pubmed | TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. | 1.42e-05 | 8 | 223 | 3 | 11907583 | |
| Pubmed | Amino acid-dependent NPRL2 interaction with Raptor determines mTOR Complex 1 activation. | 1.42e-05 | 8 | 223 | 3 | 26582740 | |
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 1.42e-05 | 8 | 223 | 3 | 30205047 | |
| Pubmed | 1.42e-05 | 8 | 223 | 3 | 31537781 | ||
| Pubmed | 1.42e-05 | 8 | 223 | 3 | 23184942 | ||
| Pubmed | Neutrophil infiltration regulates clock-gene expression to organize daily hepatic metabolism. | 1.42e-05 | 8 | 223 | 3 | 33287957 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RPL24 U2AF2 AP1G1 UTP20 DNAH5 FKBP4 KIF11 KPNA1 RANBP2 RAP1B UBR4 THUMPD3 BAZ1B MSH3 HUWE1 MTOR | 1.44e-05 | 704 | 223 | 16 | 29955894 |
| Pubmed | Close encounters: regulation of vertebrate skeletal myogenesis by cell-cell contact. | 1.58e-05 | 24 | 223 | 4 | 15923648 | |
| Pubmed | RALGAPA1 PPP2R3B NCBP1 PTPN4 SYNE2 PLCL2 MICAL3 BAIAP2 FKBP4 KPNA1 RANBP2 DSP RNF213 HUWE1 YWHAH PPP4R3A CSK VANGL1 MAPK8 MAPK9 | 1.60e-05 | 1049 | 223 | 20 | 27880917 | |
| Pubmed | RPL24 TSPOAP1 BACH1 HMGCL LIN7A SERPINB5 RPTOR GLS DLAT BAIAP2 RANBP2 RAP1A DSP DOCK9 UBR4 HUWE1 YWHAH EXOC1 CTNNB1 UNC13A PCM1 | 1.60e-05 | 1139 | 223 | 21 | 36417873 | |
| Pubmed | RALGAPA1 RPL24 PTDSS1 ITGA2 STK4 AP1G1 SACS RPTOR DLAT MICAL3 BAIAP2 TRAPPC9 DSP SYNE1 ARFGEF2 YWHAH INF2 IGHG1 EXOC1 CTNNB1 MAP2K1 PTGES3 UNC13A PCM1 | 1.84e-05 | 1431 | 223 | 24 | 37142655 | |
| Pubmed | 2.12e-05 | 9 | 223 | 3 | 10523642 | ||
| Pubmed | Structural basis for the docking of mTORC1 on the lysosomal surface. | 2.12e-05 | 9 | 223 | 3 | 31601708 | |
| Pubmed | 2.12e-05 | 9 | 223 | 3 | 11279232 | ||
| Pubmed | Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2. | 2.12e-05 | 9 | 223 | 3 | 11279118 | |
| Pubmed | 2.12e-05 | 9 | 223 | 3 | 25098452 | ||
| Pubmed | Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. | 2.12e-05 | 9 | 223 | 3 | 14633987 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL24 U2AF2 NCBP1 LRCH1 RBM27 RBM19 GLS UTP20 BAIAP2 FKBP4 KIF11 KPNA1 RAP1B DSP BTBD10 BAZ1B OAS3 TRIM27 YWHAH KIF20B USP39 CTNNB1 | 2.21e-05 | 1257 | 223 | 22 | 36526897 |
| Pubmed | RPL24 PTDSS1 AP1G1 RBM19 GNG5 KIF11 GNPAT RANBP2 DOCK9 UBR4 VPS50 ARFGEF2 RNF213 OAS2 MSH3 HUWE1 MTOR ENTPD1 EXOC1 IL2RG PCM1 | 2.31e-05 | 1168 | 223 | 21 | 19946888 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | U2AF2 NCBP1 KIF11 KPNA1 CCZ1B RANBP2 DSP ARFGEF2 HUWE1 RNF17 CSK CCZ1 EXOC1 USP39 | 2.70e-05 | 582 | 223 | 14 | 20467437 |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 2.93e-05 | 92 | 223 | 6 | 15840729 | |
| Pubmed | In silico prediction of physical protein interactions and characterization of interactome orphans. | 2.94e-05 | 136 | 223 | 7 | 25402006 | |
| Pubmed | OBSCN HMGCL PLEKHH1 AP1G1 KPNA1 RAP1A RAP1B UBR4 RNF213 MTOR | 2.99e-05 | 304 | 223 | 10 | 32235678 | |
| Pubmed | The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway. | 3.02e-05 | 10 | 223 | 3 | 37081115 | |
| Pubmed | 3.02e-05 | 10 | 223 | 3 | 33570093 | ||
| Pubmed | 3.02e-05 | 10 | 223 | 3 | 12788955 | ||
| Pubmed | 3.45e-05 | 29 | 223 | 4 | 14563677 | ||
| Pubmed | TRAF2 U2AF2 RPTOR CRNN DLAT KPNA1 BRWD1 VPS50 RPP38 BAZ1B BIRC2 RNF213 OAS3 TRIM27 YWHAH ZNF43 VANGL1 NEURL1 WDFY3 PCM1 | 3.82e-05 | 1116 | 223 | 20 | 31753913 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 13679863 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 25807985 | ||
| Pubmed | C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media. | 4.09e-05 | 2 | 223 | 2 | 25311344 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 16043490 | ||
| Pubmed | Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. | 4.09e-05 | 2 | 223 | 2 | 16818881 | |
| Pubmed | JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis. | 4.09e-05 | 2 | 223 | 2 | 21839715 | |
| Pubmed | Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. | 4.09e-05 | 2 | 223 | 2 | 15890649 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 19596001 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 11792814 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 12871971 | ||
| Pubmed | Rap1 Is Essential for B-Cell Locomotion, Germinal Center Formation and Normal B-1a Cell Population. | 4.09e-05 | 2 | 223 | 2 | 34140948 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 11435459 | ||
| Pubmed | Glutamine deprivation stimulates mTOR-JNK-dependent chemokine secretion. | 4.09e-05 | 2 | 223 | 2 | 25254627 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 29222111 | ||
| Interaction | RAB7A interactions | RALGAPA1 SLC35E1 U2AF2 HMGCL RHOU DMXL1 SH3BP4 RPTOR SYNE2 DIAPH2 GNG5 DOP1B CCZ1B RAP1A RAP1B ARFGEF2 HUWE1 HPS3 PIKFYVE VPS13D CCZ1 INF2 VANGL1 RRAGA MAP2K1 | 9.33e-06 | 886 | 215 | 25 | int:RAB7A |
| Interaction | RHOF interactions | DOCK11 PTDSS1 SLCO3A1 ITGA2 SH3BP4 TMTC3 DIAPH2 ANTXR1 UTP20 BAIAP2 KPNA1 RAP1B DOCK9 ARFGEF2 MSH3 PIKFYVE INF2 MTOR VANGL1 CTNNB1 MAP2K1 | 1.15e-05 | 673 | 215 | 21 | int:RHOF |
| Interaction | TAFA3 interactions | 1.98e-05 | 78 | 215 | 7 | int:TAFA3 | |
| Interaction | RHOQ interactions | RALGAPA1 DOCK11 ITGA2 DMXL1 SH3BP4 RPTOR DIAPH2 ANTXR1 MICAL3 BAIAP2 RAP1B DOCK9 MTOR VANGL1 RRAGA CTNNB1 | 2.28e-05 | 442 | 215 | 16 | int:RHOQ |
| Interaction | YWHAZ interactions | RALGAPA1 TRAF2 DOCK11 U2AF2 LRCH1 MEF2C SH3BP4 FSIP2 PTPN4 RBM27 RPTOR SYNE2 DLAT BAIAP2 FKBP4 KIF11 ROGDI DOCK9 HUWE1 YWHAH VPS13D CSK MTOR IGHG1 PLEKHA3 CNKSR3 WDFY3 CTNNB1 MAPK8 MAP2K1 PCM1 | 2.85e-05 | 1319 | 215 | 31 | int:YWHAZ |
| Interaction | LYG2 interactions | 2.86e-05 | 56 | 215 | 6 | int:LYG2 | |
| Interaction | CDC42 interactions | RALGAPA1 TRAF2 DOCK11 PTDSS1 U2AF2 LRCH1 RHOU SH3BP4 RHOV SYNE2 GLS DIAPH2 ANTXR1 UTP20 BAIAP2 KPNA1 RAP1A RAP1B DSP SYNE1 DOCK9 BIRC2 MSH3 HUWE1 YWHAH INF2 VANGL1 CTNNB1 MAPK8 MAPK9 PCM1 | 3.02e-05 | 1323 | 215 | 31 | int:CDC42 |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.61e-05 | 134 | 150 | 8 | 861 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 1.05e-04 | 30 | 150 | 4 | 959 | |
| GeneFamily | Dyneins, axonemal | 3.49e-04 | 17 | 150 | 3 | 536 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 4.06e-04 | 4 | 150 | 2 | 1252 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 4.06e-04 | 4 | 150 | 2 | 1332 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 4.06e-04 | 4 | 150 | 2 | 649 | |
| GeneFamily | UNC13 homologs | 4.06e-04 | 4 | 150 | 2 | 836 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 6.73e-04 | 5 | 150 | 2 | 1086 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.79e-04 | 50 | 150 | 4 | 1293 | |
| GeneFamily | Olfactory receptors, family 11 | 8.78e-04 | 23 | 150 | 3 | 159 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 1.40e-03 | 7 | 150 | 2 | 653 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.72e-03 | 115 | 150 | 5 | 769 | |
| GeneFamily | Mitogen-activated protein kinases | 5.02e-03 | 13 | 150 | 2 | 651 | |
| GeneFamily | ATP binding cassette subfamily C | 5.02e-03 | 13 | 150 | 2 | 807 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.42e-03 | 43 | 150 | 3 | 409 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | RALGAPA1 RPL24 DCK DMXL1 IFIH1 SAMD9L SACS GLS TASOR RANBP2 RAP1B ICE2 SLC35B3 ARFGEF2 BIRC2 OAS2 OAS3 IBTK GET4 IGHG1 N4BP2 ZNF721 FIGNL1 ZMYM6 ZNF639 | 9.72e-10 | 687 | 221 | 25 | M41022 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 RPL24 DOCK11 MATK PTDSS1 LYSMD2 STK4 PTPN4 SLAMF6 HEG1 SAMD9L TRANK1 SACS RBM27 GLS TASOR SMURF2 BRWD1 RANBP2 RAP1A RAP1B GPR65 SYNE1 DOCK9 UBR4 BAZ1B BIRC2 RNF213 OAS2 HUWE1 PPP4R3A PIKFYVE CSK ZNF721 MAP2K1 PTGES3 IL2RG PCM1 | 9.73e-10 | 1492 | 221 | 38 | M40023 |
| Coexpression | HALLMARK_PI3K_AKT_MTOR_SIGNALING | 2.73e-07 | 105 | 221 | 9 | M5923 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RALGAPA1 U2AF2 DCK MEF2A MEF2C DMXL1 ABCB4 SH3BP4 NOD1 SACS SYNE2 GLS PLCL2 TASOR SMURF2 GNPAT KPNA1 CCZ1B MTF2 ICE2 RPP38 ARFGEF2 MSH3 TRIM27 ATP10A IBTK CCZ1 ENTPD1 PCM1 | 4.56e-07 | 1215 | 221 | 29 | M41122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MEF2A PTPN4 HEG1 SACS SYNE2 UTP20 MICAL3 TASOR SMURF2 KIF11 DOP1B RANBP2 RAP1A MTF2 DOCK9 BAZ1B MSH3 KIF20B PIKFYVE IBTK WDFY3 MAPK8 MAP2K1 | 1.09e-06 | 856 | 221 | 23 | M4500 |
| Coexpression | ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP | 2.55e-06 | 72 | 221 | 7 | M41023 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | BACH1 LYSMD2 ITGA2 GCNT4 STAT2 IFIH1 SAMD9L TRANK1 DDX60L SMURF2 BIRC2 OAS3 ATP10A PLD5 | 4.47e-06 | 378 | 221 | 14 | M34022 |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN | STAT2 DMXL1 IFIH1 SAMD9L TRANK1 DDX60L RNF213 OAS2 OAS3 ATP10A | 6.61e-06 | 195 | 221 | 10 | M4292 |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | STAT2 IFIH1 HEG1 SAMD9L TRANK1 DDX60L BIRC2 RNF213 OAS2 OAS3 | 7.23e-06 | 197 | 221 | 10 | M7543 |
| Coexpression | ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP | 7.91e-06 | 119 | 221 | 8 | M41139 | |
| Coexpression | GSE360_DC_VS_MAC_UP | 8.26e-06 | 200 | 221 | 10 | M5172 | |
| Coexpression | GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP | TRAF2 SLCO3A1 FRMD4B NOD1 GLS GPR65 SLC43A1 UBR4 BIRC2 MAP2K1 | 8.26e-06 | 200 | 221 | 10 | M4387 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ZNF302 DMXL1 IFIH1 SACS RBM27 SYNE2 TASOR KIF11 ICE2 THUMPD3 BAZ1B BIRC2 MSH3 KIF20B ZNF43 EXOC1 LUM PCM1 | 1.28e-05 | 656 | 221 | 18 | M18979 |
| Coexpression | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN | DOCK11 BACH1 SLC35E1 LYSMD2 IFIH1 HEG1 SAMD9L PLCL2 RNF213 OAS2 OAS3 WDPCP NBPF1 PCM1 | 3.80e-05 | 458 | 221 | 14 | M4785 |
| Coexpression | QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP | 4.21e-05 | 46 | 221 | 5 | M41048 | |
| Coexpression | QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP | 4.21e-05 | 46 | 221 | 5 | M41047 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN | 4.23e-05 | 194 | 221 | 9 | M4227 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN | 4.58e-05 | 196 | 221 | 9 | M4267 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN | 4.95e-05 | 198 | 221 | 9 | M4264 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 5.15e-05 | 199 | 221 | 9 | M3070 | |
| Coexpression | BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE | 5.20e-05 | 78 | 221 | 6 | M2532 | |
| Coexpression | GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN | 5.35e-05 | 200 | 221 | 9 | M3288 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP | 5.35e-05 | 200 | 221 | 9 | M8564 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 5.35e-05 | 200 | 221 | 9 | M7320 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP | 5.35e-05 | 200 | 221 | 9 | M7322 | |
| Coexpression | GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 5.35e-05 | 200 | 221 | 9 | M7613 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 6.70e-05 | 160 | 221 | 8 | M8664 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | TRAF2 LYSMD2 ITGA2 SSTR2 STAT2 PLEKHH1 RGMA IFIH1 ODF2L SAMD9L NOD1 TRANK1 DDX60L DSP PLEKHG7 RNF213 OAS2 OAS3 POU5F1B ATP10A NEURL1 | 8.31e-05 | 973 | 221 | 21 | M41080 |
| Coexpression | TERAO_AOX4_TARGETS_SKIN_DN | 8.59e-05 | 28 | 221 | 4 | MM925 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | DCK SACS RBM27 KIF11 RAP1B SYNE1 ARFGEF2 BIRC2 C8orf76 PTGES3 | 1.12e-04 | 272 | 221 | 10 | M15123 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP | 1.20e-04 | 174 | 221 | 8 | M40888 | |
| Coexpression | MOSERLE_IFNA_RESPONSE | 1.29e-04 | 31 | 221 | 4 | M3218 | |
| Coexpression | HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | FRMD4B STAT2 IFIH1 SAMD9L NOD1 GLS DDX60L CACNA1E GPR65 RNF213 OAS2 OAS3 | 1.41e-04 | 394 | 221 | 12 | M40996 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP | 1.47e-04 | 32 | 221 | 4 | M41111 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | TSPAN19 SLCO3A1 ODF2L SYNE2 CC2D2A BAIAP2 DNAH5 DNAH9 IQUB DSP PLEKHG7 SYNE1 RPP38 OAS2 MSH3 ODAD2 DNAH7 YWHAH RRAGA PTGES3 PCM1 CFAP46 | 1.53e-04 | 1093 | 221 | 22 | M41649 |
| Coexpression | YAGI_AML_WITH_11Q23_REARRANGED | MEF2C LIN7A CLN5 DOP1B RANBP2 LALBA VPS13D ENTPD1 LUM MAPK9 IL2RG | 1.85e-04 | 346 | 221 | 11 | M17123 |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.87e-04 | 34 | 221 | 4 | M41094 | |
| Coexpression | PGF_UP.V1_UP | 2.20e-04 | 190 | 221 | 8 | M2674 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN | 2.44e-04 | 193 | 221 | 8 | M4284 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP | 2.44e-04 | 193 | 221 | 8 | M9233 | |
| Coexpression | GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 2.53e-04 | 194 | 221 | 8 | M6493 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | RALGAPA1 ZNF302 EPM2AIP1 PLEKHH1 ZNF43 PLEKHA3 C8orf76 ZMYM6 | 2.71e-04 | 196 | 221 | 8 | M7124 |
| Coexpression | GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN | 2.90e-04 | 198 | 221 | 8 | M3302 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN | 2.90e-04 | 198 | 221 | 8 | M4272 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP | 3.00e-04 | 199 | 221 | 8 | M3478 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 3.00e-04 | 199 | 221 | 8 | M6108 | |
| Coexpression | GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN | 3.11e-04 | 200 | 221 | 8 | M4659 | |
| Coexpression | GSE13229_IMM_VS_INTMATURE_NKCELL_UP | 3.11e-04 | 200 | 221 | 8 | M3209 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 3.11e-04 | 200 | 221 | 8 | M8306 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 3.11e-04 | 200 | 221 | 8 | M9588 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | 3.11e-04 | 200 | 221 | 8 | M8559 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 3.11e-04 | 200 | 221 | 8 | M8554 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN | 3.11e-04 | 200 | 221 | 8 | M3868 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 3.11e-04 | 200 | 221 | 8 | M5030 | |
| Coexpression | GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP | 3.11e-04 | 200 | 221 | 8 | M6424 | |
| Coexpression | GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN | 3.11e-04 | 200 | 221 | 8 | M6475 | |
| Coexpression | HALLMARK_INTERFERON_GAMMA_RESPONSE | 3.11e-04 | 200 | 221 | 8 | M5913 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 3.11e-04 | 200 | 221 | 8 | M5261 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN | 3.11e-04 | 200 | 221 | 8 | M4269 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 3.11e-04 | 200 | 221 | 8 | M9133 | |
| Coexpression | GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 3.11e-04 | 200 | 221 | 8 | M3067 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 3.21e-04 | 39 | 221 | 4 | M41095 | |
| Coexpression | BORCZUK_MALIGNANT_MESOTHELIOMA_UP | 3.22e-04 | 310 | 221 | 10 | M10236 | |
| Coexpression | BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP | 3.55e-04 | 204 | 221 | 8 | M34006 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | TSPAN19 ODF2L CC2D2A DNAH5 DNAH9 IQUB PLEKHG7 ODAD2 DNAH7 CFAP46 | 3.84e-04 | 317 | 221 | 10 | M40298 |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP | LYSMD2 MEF2C STAT2 IFIH1 SAMD9L NOD1 TRANK1 DDX60L GPR37 BIRC2 RNF213 OAS2 OAS3 ATP10A LINS1 | 4.01e-04 | 644 | 221 | 15 | M34026 |
| Coexpression | GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP | 4.32e-04 | 160 | 221 | 7 | M339 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | IFIH1 PTPN4 ODF2L SAMD9L TRANK1 SYNE2 DSP SYNE1 RNF213 OAS2 OAS3 IGHG1 IL2RG | 2.81e-11 | 199 | 223 | 13 | 952fac67588ad5676f5939e3c7f8bac803c27064 |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | FRMD4B STAT2 IFIH1 SAMD9L TRANK1 DDX60L DNAH9 FKBP4 PLEKHG7 RNF213 OAS2 OAS3 | 1.07e-10 | 177 | 223 | 12 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | FRMD4B STAT2 IFIH1 SAMD9L TRANK1 DDX60L DNAH9 FKBP4 PLEKHG7 RNF213 OAS2 OAS3 | 1.15e-10 | 178 | 223 | 12 | ef6111238703579a34bd6948bd9d4ca6b7e16063 |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | STAT2 IFIH1 ODF2L SAMD9L NOD1 TRANK1 SYNE2 DDX60L RNF213 OAS2 OAS3 ATP10A | 2.16e-10 | 188 | 223 | 12 | 6f8946d4710f6e32c937213f99b790b098b8819c |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | MATK PTPN4 ODF2L SAMD9L TRANK1 SYNE2 SYNE1 RNF213 OAS2 OAS3 RNF17 IL2RG | 3.29e-10 | 195 | 223 | 12 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | STAT2 DMXL1 IFIH1 SAMD9L TRANK1 DDX60L DSP PLEKHG7 RNF213 OAS2 OAS3 ATP10A | 3.29e-10 | 195 | 223 | 12 | b64d9e1a8834401b4dc501566546647754ae21fc |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | TSPOAP1 SLAMF6 SAMD9L TRANK1 SYNE2 SYNE1 RNF213 OAS2 OAS3 PPP4R3A CXCR2 | 1.64e-09 | 177 | 223 | 11 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | TSPOAP1 SLAMF6 SAMD9L TRANK1 SYNE2 SYNE1 RNF213 OAS2 OAS3 PPP4R3A CXCR2 | 1.64e-09 | 177 | 223 | 11 | f8f101c772c043636bedd6b2ec81409b1d2599bf |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | TSPOAP1 SLAMF6 SAMD9L TRANK1 SYNE2 SYNE1 RNF213 OAS2 OAS3 PPP4R3A CXCR2 | 1.64e-09 | 177 | 223 | 11 | 6978a22fef40c8b455342373abe7593f5ede0fa4 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | TSPOAP1 SLAMF6 SAMD9L TRANK1 SYNE2 SYNE1 RNF213 OAS2 OAS3 PPP4R3A CXCR2 | 1.64e-09 | 177 | 223 | 11 | 936ab2b180a052387124f68d0c7f41c0b164e748 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | TSPOAP1 SLAMF6 SAMD9L TRANK1 SYNE2 SYNE1 RNF213 OAS2 OAS3 PPP4R3A CXCR2 | 1.64e-09 | 177 | 223 | 11 | d5aeda113afaa2425874394610344570c9078478 |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | STAT2 IFIH1 ODF2L SAMD9L NOD1 TRANK1 DDX60L DNAH9 RNF213 OAS2 OAS3 | 1.85e-09 | 179 | 223 | 11 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | STAT2 DMXL1 IFIH1 SAMD9L TRANK1 MICAL3 DDX60L DSP PLEKHG7 OAS2 OAS3 | 2.33e-09 | 183 | 223 | 11 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | STAT2 IFIH1 ODF2L SAMD9L TRANK1 SYNE2 DDX60L RNF213 OAS2 OAS3 LINS1 | 5.62e-09 | 199 | 223 | 11 | 056a0538ca5e825ae6195b4c76c208708a014533 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | PTPN4 SLAMF6 SAMD9L TRANK1 SYNE2 SYNE1 RNF213 OAS2 OAS3 HUWE1 CXCR2 | 5.92e-09 | 200 | 223 | 11 | 2281debd86e5d92e8fe0397aec9ef670800f7471 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.60e-09 | 118 | 223 | 9 | f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.60e-09 | 118 | 223 | 9 | c5c6724e0e526d7c2fc8cabff4a112a900ec997f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-09 | 118 | 223 | 9 | 0dcac16eea8e7978de370a815da9a0cdd212598e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-09 | 118 | 223 | 9 | 7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4 | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 9.26e-09 | 119 | 223 | 9 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MEF2A IFIH1 SAMD9L SYNE2 DIAPH2 TASOR RANBP2 SYNE1 BAZ1B PCM1 | 2.41e-08 | 178 | 223 | 10 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.13e-08 | 183 | 223 | 10 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | TSPOAP1 SAMD9L TRANK1 SYNE1 RNF213 OAS2 OAS3 PPP4R3A FBH1 CXCR2 | 3.13e-08 | 183 | 223 | 10 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | LYSMD2 IFIH1 SAMD9L TRANK1 PKHD1 DDX60L GPR65 RNF213 OAS2 OAS3 | 3.47e-08 | 185 | 223 | 10 | f30fb9d75cdb757b206312992aaf7485bc900f96 |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.69e-08 | 191 | 223 | 10 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.43e-08 | 194 | 223 | 10 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.43e-08 | 194 | 223 | 10 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | TSPAN19 DIAPH2 CC2D2A DNAH5 DNAH9 IQUB SYNE1 ODAD2 DNAH7 CFAP46 | 5.70e-08 | 195 | 223 | 10 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | LYSMD2 STAT2 IFIH1 ODF2L SAMD9L TRANK1 ATRIP DDX60L OAS2 OAS3 | 5.98e-08 | 196 | 223 | 10 | 417b4fc2e4388f34c410576131b02936f93e46b6 |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | IFIH1 SAMD9L TRANK1 DDX60L RNF213 OAS2 OAS3 MAP2K6 IL2RG CXCR2 | 5.98e-08 | 196 | 223 | 10 | ded44b38ea489946e9eedfe752b5a9fde9149c16 |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | TSPAN19 DIAPH2 CC2D2A DNAH5 DNAH9 IQUB SYNE1 ODAD2 DNAH7 CFAP46 | 6.27e-08 | 197 | 223 | 10 | 71fea4aa6ce96c7693fa94792d08770622873850 |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | TSPAN19 DIAPH2 CC2D2A DNAH5 DNAH9 IQUB SYNE1 ODAD2 DNAH7 CFAP46 | 6.27e-08 | 197 | 223 | 10 | e453d085182364ca347cbcc9dc995c62c3353016 |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | TSPAN19 DIAPH2 CC2D2A DNAH5 DNAH9 IQUB SYNE1 ODAD2 DNAH7 CFAP46 | 6.27e-08 | 197 | 223 | 10 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | PTPN4 SAMD9L SYNE2 DDX60L RAP1B SYNE1 RNF213 PTGES3 IL2RG PCM1 | 6.58e-08 | 198 | 223 | 10 | 8165ff735095c52994fb5057d89be93cc378b7da |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | STAT2 IFIH1 ODF2L SAMD9L TRANK1 SYNE2 DDX60L RNF213 OAS2 OAS3 | 6.58e-08 | 198 | 223 | 10 | 4b078714c49e7befb7b113d72485e712236d35fa |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | IFIH1 SAMD9L TRANK1 SYNE2 DOCK9 OAS2 OAS3 FAM228A PLA2R1 ZBTB46 | 6.58e-08 | 198 | 223 | 10 | ee71543559836fd59adc0da877b2ca538cba60cb |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | NUGGC SLAMF6 HEG1 SAMD9L TRANK1 SYNE2 SYNE1 RNF213 OAS2 OAS3 | 6.58e-08 | 198 | 223 | 10 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | TSPAN19 DIAPH2 CC2D2A DNAH5 DNAH9 IQUB SYNE1 ODAD2 DNAH7 CFAP46 | 6.58e-08 | 198 | 223 | 10 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | OBSCN IFIH1 SAMD9L TRANK1 SYNE2 DOCK9 RNF213 OAS2 OAS3 NBPF1 | 7.23e-08 | 200 | 223 | 10 | d9e8a0d047d4403fb7265fde7448e23a7780785c |
| ToppCell | Control-CD4+_T_activated|Control / Disease condition and Cell class | 1.29e-07 | 116 | 223 | 8 | e3d1a90a229f5697b2b715574bb96790a435f73b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-07 | 169 | 223 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.61e-07 | 182 | 223 | 9 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 3.61e-07 | 182 | 223 | 9 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.61e-07 | 182 | 223 | 9 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-07 | 182 | 223 | 9 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-07 | 182 | 223 | 9 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 3.78e-07 | 183 | 223 | 9 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 4.54e-07 | 187 | 223 | 9 | 4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.96e-07 | 189 | 223 | 9 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-07 | 189 | 223 | 9 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.96e-07 | 189 | 223 | 9 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.19e-07 | 190 | 223 | 9 | 88c092a5e78ccaddf406f8fff74376bb761b9790 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.19e-07 | 190 | 223 | 9 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.19e-07 | 190 | 223 | 9 | 9501f0995f3d52be90c02b1aa0c7d184bd788c16 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.19e-07 | 190 | 223 | 9 | b9182c84e44aa31684b5388cf3ef4fd1b9e51de4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.19e-07 | 190 | 223 | 9 | 4b42a16902d7d1494f953cc88af1e761e76bdf2c | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.19e-07 | 190 | 223 | 9 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.19e-07 | 190 | 223 | 9 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.42e-07 | 191 | 223 | 9 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.18e-07 | 194 | 223 | 9 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 6.18e-07 | 194 | 223 | 9 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.18e-07 | 194 | 223 | 9 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 6.45e-07 | 195 | 223 | 9 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | T/NK_cells-CD8+_Naive_T_cell|World / Lineage and Cell class | 6.45e-07 | 195 | 223 | 9 | 43f11068beea076e9caeb1572215c3f65c9308e1 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 6.45e-07 | 195 | 223 | 9 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.73e-07 | 196 | 223 | 9 | 5b5cf6f70534661d694f47359b6595b4580876c3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.73e-07 | 196 | 223 | 9 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | Mild-CD4+_T_activated|Mild / Disease group and Cell class | 6.73e-07 | 196 | 223 | 9 | daa1c3322d81e649161e889e1d78451d2d425d09 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-07 | 196 | 223 | 9 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | Mild|World / Disease group and Cell class | 6.73e-07 | 196 | 223 | 9 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.73e-07 | 196 | 223 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 6.73e-07 | 196 | 223 | 9 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.73e-07 | 196 | 223 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.73e-07 | 196 | 223 | 9 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.73e-07 | 196 | 223 | 9 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-07 | 196 | 223 | 9 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.02e-07 | 197 | 223 | 9 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 7.02e-07 | 197 | 223 | 9 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.02e-07 | 197 | 223 | 9 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.02e-07 | 197 | 223 | 9 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.02e-07 | 197 | 223 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 7.02e-07 | 197 | 223 | 9 | 4711ecb157e907758a5021248ae8b043d17672c6 | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 7.02e-07 | 197 | 223 | 9 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.32e-07 | 198 | 223 | 9 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.32e-07 | 198 | 223 | 9 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.32e-07 | 198 | 223 | 9 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.32e-07 | 198 | 223 | 9 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.32e-07 | 198 | 223 | 9 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | BAL-Severe|BAL / Compartment, Disease Groups and Clusters | 7.32e-07 | 198 | 223 | 9 | f63cfcc57f46094ea0673bbc70ea443ebaca6176 | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 7.64e-07 | 199 | 223 | 9 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.64e-07 | 199 | 223 | 9 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.64e-07 | 199 | 223 | 9 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 7.64e-07 | 199 | 223 | 9 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.64e-07 | 199 | 223 | 9 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.64e-07 | 199 | 223 | 9 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.96e-07 | 200 | 223 | 9 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.96e-07 | 200 | 223 | 9 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.96e-07 | 200 | 223 | 9 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.96e-07 | 200 | 223 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 7.96e-07 | 200 | 223 | 9 | b7f80b2db07119069fbf3d245cf1ad79e8648bab | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | KLHL24 NCBP1 KLHL29 HEG1 NOD1 RBM19 ANTXR1 KPNA1 VPS50 VPS13D NEURL1 WDFY3 | 5.15e-07 | 196 | 221 | 12 | 3416_UP |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | KLHL24 HEG1 RBM19 ANTXR1 MTF2 BAZ1B OAS2 PPP4R3A NEURL1 WDFY3 PCM1 | 3.27e-06 | 194 | 221 | 11 | 3604_DN |
| Disease | Kabuki make-up syndrome | 2.97e-04 | 4 | 209 | 2 | C0796004 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.97e-04 | 4 | 209 | 2 | cv:CN293514 | |
| Disease | Intellectual Disability | RALGAPA1 HMGCL MEF2C SACS CACNA1E SYNE1 LINS1 FRY MTOR ENTPD1 ZMYM6 | 3.73e-04 | 447 | 209 | 11 | C3714756 |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.92e-04 | 5 | 209 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.92e-04 | 5 | 209 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.35e-04 | 6 | 209 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.35e-04 | 6 | 209 | 2 | C0410189 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 7.35e-04 | 6 | 209 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.01e-03 | 28 | 209 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | mean platelet volume | SETD1B DOCK11 ITGA2 LRCH1 MEF2C KLHL29 STK4 TRANK1 SYNE2 GLS TASOR PCDHGA6 NARF FRY RRAGA MAP2K1 PTGES3 | 1.01e-03 | 1020 | 209 | 17 | EFO_0004584 |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.02e-03 | 7 | 209 | 2 | C0751337 | |
| Disease | Periventricular Nodular Heterotopia | 1.02e-03 | 7 | 209 | 2 | C1868720 | |
| Disease | Cholestasis of pregnancy | 1.36e-03 | 8 | 209 | 2 | C0268318 | |
| Disease | Colorectal Carcinoma | OBSCN ABCB4 SERPINB5 SACS PKHD1 ABCC2 IQUB UNC13B SYNE1 HPS3 ZNF43 NEURL1 CTNNB1 | 1.59e-03 | 702 | 209 | 13 | C0009402 |
| Disease | temporal lobe epilepsy (implicated_via_orthology) | 1.74e-03 | 9 | 209 | 2 | DOID:3328 (implicated_via_orthology) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.74e-03 | 9 | 209 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 1.74e-03 | 9 | 209 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.01e-03 | 75 | 209 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | JT interval | 2.02e-03 | 248 | 209 | 7 | EFO_0007885 | |
| Disease | feeling "fed-up" measurement | 2.11e-03 | 76 | 209 | 4 | EFO_0009588 | |
| Disease | pancreatic adenocarcinoma (is_marker_for) | 2.16e-03 | 10 | 209 | 2 | DOID:4074 (is_marker_for) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.28e-03 | 37 | 209 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | cortical thickness | KLHL24 LRCH1 FRMD4B MEF2C KLHL29 SLAMF6 GLS PKHD1 MICAL3 DOCK9 ARFGEF2 MSH3 KIF20B PPP4R3A VPS13D CSK CNKSR3 | 2.54e-03 | 1113 | 209 | 17 | EFO_0004840 |
| Disease | Lymphoma, Lymphocytic, Intermediate | 2.63e-03 | 11 | 209 | 2 | C0751958 | |
| Disease | Moyamoya disease | 2.85e-03 | 40 | 209 | 3 | MONDO_0016820 | |
| Disease | PR interval | TRHR OBSCN LRCH1 FRMD4B SERPINB5 SYNE2 UBE3B GET4 RANBP3L CNKSR3 | 2.94e-03 | 495 | 209 | 10 | EFO_0004462 |
| Disease | Allodynia | 3.03e-03 | 84 | 209 | 4 | C0458247 | |
| Disease | Mechanical Allodynia | 3.03e-03 | 84 | 209 | 4 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 3.03e-03 | 84 | 209 | 4 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.03e-03 | 84 | 209 | 4 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.03e-03 | 84 | 209 | 4 | C0751214 | |
| Disease | Tactile Allodynia | 3.03e-03 | 84 | 209 | 4 | C0751213 | |
| Disease | Hyperalgesia | 3.03e-03 | 84 | 209 | 4 | C0020429 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.14e-03 | 12 | 209 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Trigeminal Neuralgia | 3.14e-03 | 12 | 209 | 2 | C0040997 | |
| Disease | Secondary Trigeminal Neuralgia | 3.14e-03 | 12 | 209 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 3.14e-03 | 12 | 209 | 2 | C0393786 | |
| Disease | volumetric bone mineral density | 3.28e-03 | 42 | 209 | 3 | EFO_0007620 | |
| Disease | depressive symptom measurement | 3.51e-03 | 426 | 209 | 9 | EFO_0007006 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 3.99e-03 | 45 | 209 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | red blood cell density measurement | RALGAPA1 MEF2C TMTC3 PLCL2 PKHD1 CC2D2A ANTXR1 TASOR KIF11 ARFGEF2 KIF20B PPP4R3A ZBTB46 PDE8B | 4.21e-03 | 880 | 209 | 14 | EFO_0007978 |
| Disease | Kartagener syndrome (implicated_via_orthology) | 4.30e-03 | 14 | 209 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 4.30e-03 | 14 | 209 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | Primary Ciliary Dyskinesia | 4.52e-03 | 47 | 209 | 3 | C4551720 | |
| Disease | Adenocarcinoma of large intestine | 4.89e-03 | 96 | 209 | 4 | C1319315 | |
| Disease | Meckel-Gruber syndrome | 4.93e-03 | 15 | 209 | 2 | C0265215 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.93e-03 | 15 | 209 | 2 | C0496930 | |
| Disease | Situs ambiguus | 4.93e-03 | 15 | 209 | 2 | C0266642 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 4.93e-03 | 15 | 209 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | Benign neoplasm of bladder | 4.93e-03 | 15 | 209 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 4.93e-03 | 15 | 209 | 2 | C0154091 | |
| Disease | coronary artery calcification | 5.01e-03 | 450 | 209 | 9 | EFO_0004723 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 5.08e-03 | 49 | 209 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 5.61e-03 | 16 | 209 | 2 | C0334634 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 5.61e-03 | 16 | 209 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Influenza | 6.00e-03 | 52 | 209 | 3 | C0021400 | |
| Disease | hypertension | 6.48e-03 | 307 | 209 | 7 | EFO_0000537 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVLKCLDFSLVVNVK | 481 | Q8TAA9 | |
| DSNLTLFAKICEKTV | 1356 | Q9UPW8 | |
| AVCAILFKENSIVKV | 41 | Q86W67 | |
| LKFKFLDSTADQQEC | 126 | O14867 | |
| DFQCVKSKSITNLAA | 416 | Q9BSF8 | |
| LCSFKINDSVTLNEK | 256 | Q9H6X2 | |
| KAVFDCVVTSLKNVF | 1276 | Q15878 | |
| LSLLDKFLIKNCNDF | 101 | Q04917 | |
| KACVNFLETSLEAKN | 226 | Q96KE9 | |
| CVIALQASVIKKFLQ | 1096 | Q9UIG0 | |
| QKDAFLVFRSLCKLS | 371 | Q9Y6D5 | |
| ANQKLFASLLIKCVV | 1541 | Q9Y6D5 | |
| ATVCHIFQKLINAFK | 1696 | Q8IYW2 | |
| VKCIKNDATAQAFLA | 221 | P41240 | |
| FKINFLCKIRDTKSA | 856 | O60879 | |
| KCLKFVVSNAENLVD | 46 | Q6UXS9 | |
| ETFIKNIFTKKRCLN | 2606 | Q9Y485 | |
| NLEDKFLFLAKQCRS | 986 | O60312 | |
| SLEFQDFVNKCLIKN | 331 | Q02750 | |
| ILKQSCFIIFEDSSK | 71 | Q9Y483 | |
| AALFKCKFEEAQSIL | 1291 | P49792 | |
| FLTKQDAKRAFNALC | 881 | Q9Y4C8 | |
| CAFLESSAKSKINVN | 141 | P62834 | |
| CAFLESSAKSKINVN | 141 | P61224 | |
| KAFCADQLDVFLQKE | 46 | Q9P2N5 | |
| LSCLFQSEKANTLKA | 161 | Q9ULJ1 | |
| QDLKRCKLANVFFDT | 456 | Q9Y5P8 | |
| NFVKLQVKACALSQI | 31 | O95825 | |
| LQQFCSKKLFSIPEE | 1321 | O95153 | |
| ISFKCKQFFIQLRKE | 261 | P29074 | |
| LVNFLKEFCAFSQTL | 331 | Q6IN85 | |
| KKCVQSNIVLLTQAF | 201 | O94925 | |
| FLSKACSDFLIKSIN | 136 | Q8NAB2 | |
| SSLQNLEKTIFCLQK | 141 | Q96K31 | |
| GQLECLKLIASQKFT | 66 | O43747 | |
| QKTICRFEALQLSFK | 181 | Q06416 | |
| NIVVKSDCTLKILDF | 156 | P45984 | |
| KKCSTQEFFLIVKTL | 631 | P20585 | |
| LNKTNVKFLAITTDC | 286 | P35222 | |
| ANSEISQVCATKLFK | 46 | Q6PIW4 | |
| LSEKKNISFAGCFLQ | 101 | Q8NH07 | |
| FVKITEKISQIFCLN | 281 | Q9Y5G7 | |
| QFVTLCEKEVAANSK | 121 | Q96FN9 | |
| QATTCKGTLKAFQEL | 21 | Q7RTP6 | |
| QSLKKVLQSEFCTAI | 51 | O14910 | |
| CSQKTEILKQFLTHF | 206 | Q8NG48 | |
| VKNIKCDVTAQAFLD | 261 | P42679 | |
| KRANKLFTNDCIFLK | 96 | Q8IV50 | |
| LFTNDCIFLKKTLNI | 101 | Q8IV50 | |
| ALCLAVAFKSKATND | 501 | Q09161 | |
| VFKSVTNRFIKNLAC | 71 | Q14439 | |
| QVVLCKFHSVFLSQK | 181 | Q9P2D0 | |
| TIKIGLTKLNCFLEQ | 901 | P52732 | |
| TFLCIQELIANFASK | 626 | Q9Y3R5 | |
| CKIQKLTNAISAFTL | 411 | O75387 | |
| KCLKDFAFNIQAISD | 1651 | Q5H9U9 | |
| CEENANFITKTIFKR | 2246 | Q5CZC0 | |
| SSKSVFLLNVVCEKL | 3746 | Q5CZC0 | |
| LKKQLDFSVSICQTL | 1006 | Q15154 | |
| NIVVKSDCTLKILDF | 156 | P45983 | |
| VNDFIIKASALACLK | 476 | P10515 | |
| LAFQLTVKDTKCNIF | 691 | O95263 | |
| TFLCKVVSLLKEVNF | 116 | P25025 | |
| LTESSFRNKIKCFLQ | 1206 | Q6ZU69 | |
| TLNVLKFSAIAQKVC | 466 | Q96Q89 | |
| QFTNLFLCGLLSKAK | 586 | Q9Y239 | |
| KEDNTFVCTLETLKF | 211 | Q8WVF5 | |
| AILAKQFTKCELSQL | 16 | P00709 | |
| VLKVLDCTQKAVFAV | 121 | Q96LW2 | |
| VDLSLVKFDFSCNKV | 231 | Q9Y2L9 | |
| ICIGNKNIFTVSDLK | 291 | Q8TB73 | |
| CEIALIIFNSTNKLF | 41 | Q06413 | |
| VKVSQAAADLKQFCL | 26 | P63218 | |
| KELKNLLAFSQLQCV | 531 | Q92887 | |
| KEQIKCLNNRFASFI | 121 | Q9NSB4 | |
| ICNLVRTFVTEFKLK | 1061 | Q9ULI3 | |
| CEIALIIFNSSNKLF | 41 | Q02078 | |
| ESNVKTFCSKNILAI | 6 | P49961 | |
| FLKENCFRQSTAKIQ | 376 | P29728 | |
| FLVVTQKAAFTCIKN | 1241 | Q7Z6Z7 | |
| KNAQIILKLCFSAKF | 671 | P17301 | |
| QFRNLKEKCFVTQLA | 576 | Q3BBV0 | |
| FKEFLVLVFKVAQAC | 71 | Q9UBG3 | |
| VLVFKVAQACFKTLS | 76 | Q9UBG3 | |
| LNIFLKQFKCSNEEV | 641 | Q27J81 | |
| ALQTEAIKLFKTCQL | 971 | Q8IVE3 | |
| AIKLFKTCQLFINAA | 976 | Q8IVE3 | |
| VSVIFFCLFLKNSSK | 196 | Q5TF39 | |
| FCLFLKNSSKQEKAR | 201 | Q5TF39 | |
| VKQQKCNIFSLIFLF | 746 | P21439 | |
| RFSKACLKNVFSVLL | 56 | Q9H813 | |
| VNILNCFTFSKDKLV | 71 | Q86XN7 | |
| VIICKQEINTKSAFL | 836 | Q5T6X5 | |
| QENFVLKILFCKQSD | 291 | Q5VST9 | |
| NFLAKNKSISFLGCA | 96 | Q8NG75 | |
| VFESLIAKKQSLCEV | 1486 | Q9Y2I7 | |
| DSFIILSFLAQNKLC | 171 | O95876 | |
| LSFLAQNKLCFIQFT | 176 | O95876 | |
| KTTVELFFLNAKACV | 151 | Q9Y2L6 | |
| IRAKLVCKTLENFFA | 551 | Q8NFZ0 | |
| VTEFLKFLQNSAKKC | 146 | Q659A1 | |
| KTLFTKCKNFALQTF | 181 | Q6TFL4 | |
| NIISQFLLFFKSCVT | 531 | O15354 | |
| LLQATEKFQAECALK | 1266 | Q9P2K1 | |
| FFINLALFDVKNNCK | 396 | Q5JSL3 | |
| KTFAKARNIAVCVEF | 656 | Q5JSL3 | |
| KSFAKARNIAICIEF | 656 | Q9BZ29 | |
| LSKVFKQIFSKVCVN | 126 | O15228 | |
| LAILEAKLCFFTDNK | 311 | P0C221 | |
| KCFSNIFIASKLEAV | 181 | Q9P109 | |
| KVASLFDSNQICEKA | 546 | Q7L775 | |
| TGFNLKVVLVSFKQC | 6 | Q5TA50 | |
| QAECSQFKAKLASLE | 1066 | P15924 | |
| EVKKLCATQFNNIFF | 466 | P86791 | |
| EKDKLLFSFCLTINL | 3276 | Q8WXX0 | |
| CFVEALEKASKQLRF | 321 | Q00597 | |
| CLKIRNFVVVFKNNS | 981 | Q9BYX4 | |
| EVKKLCATQFNNIFF | 466 | P86790 | |
| LEFCKDIRLIFSNAK | 1376 | Q9NSI6 | |
| LEVNQLEKFDIKSFC | 281 | P51884 | |
| LFSEEITSGCQLQKK | 106 | P31785 | |
| LSIFCRDTQTVFQKK | 281 | Q8NA54 | |
| AAGKSTFVNILKQLC | 31 | P27707 | |
| CLAEQDFISKFFKLQ | 526 | Q9NV70 | |
| LTKNQVSLTCLVKGF | 241 | P01857 | |
| SLCLKAGVKNLNTVF | 2866 | Q9NYC9 | |
| VFSSLFKNIQKRFCF | 2706 | Q5TBA9 | |
| KVLVKLAENTSCDFL | 566 | Q8WXE1 | |
| KLQAFSAAIESCNKA | 331 | Q02790 | |
| DKDFKTLCFVQINVI | 426 | Q12864 | |
| LNCKVAKVFDISSFA | 3201 | Q9NZJ4 | |
| QLALNKICSKDSAFV | 3331 | Q9NZJ4 | |
| LFVKVTNQIISACKA | 396 | Q8TE73 | |
| AAFQCIKSALQVEDK | 236 | Q3SYA9 | |
| LSEKKNISFAGCFLQ | 101 | Q8NG94 | |
| LSEKKNISFAGCFLQ | 101 | B2RN74 | |
| AQVNKAVDTICSFLK | 771 | Q9Y6K5 | |
| QQIFIEAKASKIFNC | 161 | O95157 | |
| EFVDFTSQCLKKNSK | 286 | P52564 | |
| LSQKKTISFLGCAIQ | 86 | Q8NGX5 | |
| LSQKKTISFLGCAIQ | 86 | Q6IF99 | |
| TFIFKSLGLKCVQFL | 976 | P42345 | |
| IKNQKVFSADFILTC | 36 | Q7RTR8 | |
| FSFLTLITKLIKECN | 2436 | O75691 | |
| FTVSLQLCQQLKDKI | 261 | Q9GZN7 | |
| QLCQQLKDKISVFSS | 266 | Q9GZN7 | |
| DSCKKNFLIQEISAI | 626 | Q68CJ6 | |
| AQKCLFLTESLKQFT | 281 | P14373 | |
| KSISQLKDQQDVFCF | 161 | P52630 | |
| FSVSAQKLCEDVKIQ | 206 | Q96DU3 | |
| CVLALAFKKNTTDFV | 176 | P78345 | |
| IANCSLKVKFFDLER | 406 | Q8N7P1 | |
| IKAQFLCTFSRAKKI | 131 | P34981 | |
| KKVSCFSNIKIFLVS | 31 | Q9UIG8 | |
| IKNDLFSKSTVGLQC | 401 | Q9P0V3 | |
| IFCIKRFTKNNFFVE | 451 | Q53GS9 | |
| FKIDINCKQLTVDFV | 6956 | Q8NF91 | |
| FSNIKVNLKECFESS | 1851 | Q8WXH0 | |
| VAQAVLQFLCLKNKS | 196 | Q7L5D6 | |
| LQFLCLKNKSSASVV | 201 | Q7L5D6 | |
| KNLSQEKELLSLFCF | 331 | Q969F9 | |
| EKCFVTQLAGFLAKQ | 311 | Q5TAG4 | |
| QFRSLKEKCFVTQVA | 576 | Q5TAG4 | |
| NFRCAVLKNKTTDFA | 761 | Q8IVG5 | |
| FVEFLKRKENCTLQF | 131 | P52294 | |
| ACTSVEEFQVFKKLL | 306 | Q7Z6M4 | |
| LKCLAAETIANVAKF | 551 | Q5T2S8 | |
| LITKFVVQCSNFRDK | 576 | Q9NTG1 | |
| KKNINCSIEESFQRF | 136 | P35914 | |
| LVSICKSVQFKEFQV | 621 | Q9UPR0 | |
| QFTTQFLKLHCLQKL | 261 | A6NGN4 | |
| NLSKFNKLTQFFICV | 71 | Q9H1N7 | |
| EKFAFSNALCLSVKL | 301 | Q9NWS8 | |
| SCDSDLLKFNQLKFR | 1811 | Q9UPS6 | |
| LANSAFAVDLFKQLC | 6 | P36952 | |
| LFAAVCALTQNDIKK | 286 | P03915 | |
| CALTQNDIKKIVAFS | 291 | P03915 | |
| QFTTQFLKLHCLQKL | 261 | A3QJZ7 | |
| FLQVTVNKTSCKVIF | 961 | P08F94 | |
| AATLCFSLQNIFSKK | 196 | Q96K37 | |
| QNTIKDAFKGCTVLT | 1296 | Q96J65 | |
| LTIIFKNFQECVDQK | 216 | Q96B86 | |
| SDNFKKSFQNVLCLV | 316 | P30874 | |
| KSFQNVLCLVKVSGT | 321 | P30874 | |
| FVIQSESLKKCIQAG | 41 | Q13018 | |
| CSNAGLIVKSFKQFA | 196 | Q8N122 | |
| IQCRKEFKNISAINF | 536 | Q9UK61 | |
| ANIFKNCLKEIDSTL | 521 | Q13490 | |
| FLVEKQCAVAKNSAA | 196 | Q9UQB8 | |
| CSKFVLRTFNKLAEF | 231 | O75503 | |
| ASKIFCSLQKAELAQ | 81 | Q6UVW9 | |
| ITDFSVTKNKIIQLC | 146 | G9CGD6 | |
| ITDFSVTKNKIIQLC | 146 | Q6P9H4 | |
| IECSALTQKNLKEVF | 201 | Q7L0Q8 | |
| QLLAFFDSRKKNLCE | 196 | Q9BXT8 | |
| LTVLCAKNLVKKDFF | 16 | Q9HAU4 | |
| EKKTATFENIVCVLN | 276 | Q12933 | |
| CAFLESSAKSKINVN | 141 | A6NIZ1 | |
| LTNTAKCKILIFQTD | 3366 | Q63HN8 | |
| QLDVALSKICKNFDI | 236 | Q96JG6 | |
| TECGKAFTQKSNLIV | 601 | P17025 | |
| NNIFKSCSSLAVVEK | 246 | Q8IW36 | |
| LLSKITFDKCKNFFV | 361 | Q9UID6 | |
| QLFCQKCSRFQSEIK | 3481 | Q8IZQ1 | |
| EALNVICVSLKFTNK | 1316 | Q6GYQ0 | |
| CSALTQKNLKEVFDS | 186 | Q96L33 | |
| KAVKRQASFCNAITF | 81 | O76050 | |
| FLNAKCESAFLSKRN | 31 | P83731 | |
| DVNVNFEKSKLTFSC | 26 | Q15185 | |
| KINCKLFIFNKTTQS | 301 | Q86VV4 | |
| KQFKLSCSKLAASFQ | 236 | Q7L523 | |
| KNEFQSVSLLLKCIQ | 76 | Q5T4T6 | |
| ICDLISSSKQFIKKF | 121 | Q6ZSR6 | |
| SKIFQCNARVKVFSK | 66 | Q8TF20 | |
| SLAFNLKDKVFCELF | 146 | Q8N2K1 | |
| IKQFKLSCSKLAASF | 296 | Q5VZM2 | |
| NLTLFATVCEKTVLK | 1276 | O14795 | |
| ANIGSLCVSFLQAKK | 31 | Q8IYL9 | |
| TEALKLFKSCQLFIN | 851 | Q9ULM0 | |
| FITTLEECVKIANAK | 166 | Q9HB20 | |
| TQSKIFLFDKCVKAF | 141 | P17038 | |
| AVLLTQDTKCFTKAL | 441 | Q9BV44 | |
| IFFCDILSKKLLESQ | 396 | Q7Z3V4 | |
| TFFNLCNKIDVFKRK | 1136 | O95789 | |
| KIFVEFTSVFDCQKA | 431 | P26368 | |
| FLFNDFLLVTKTKCN | 556 | Q6ZR37 | |
| SDNFTDFVKQCLVKS | 251 | Q13043 | |
| ATFTINIKVKLDFSC | 786 | Q96Q05 | |
| FLKNLKAVSKFSLLC | 256 | Q9H598 | |
| IFLKVCKLFLDNKSS | 106 | Q6ZXV5 | |
| VLLCNKSNAFFSLGK | 16 | O15050 | |
| QDCATTVFKFLLEKQ | 381 | O15050 | |
| LCTALVNQLNKFADK | 3391 | Q5T4S7 | |
| KFADKETLIQFLRCF | 3401 | Q5T4S7 | |
| SLTVCFFKNIKNIIH | 231 | P0C672 | |
| IVCIKFGQDLFSKTQ | 366 | P48651 | |
| ALKESQFTLSKCIDA | 26 | Q13889 | |
| LSLNEFTVIRKKFKC | 406 | Q86UZ6 | |
| INEDKISALKNCFAL | 886 | Q5THJ4 | |
| NKCLKVFSSFSFLVQ | 451 | Q9NR11 | |
| KVCVSFLEKQLTASN | 421 | Q96CT2 | |
| LFDQFIATKVCNRKL | 236 | Q5VXJ0 | |
| FFRVLNLNKKCDTSK | 76 | Q9UHQ1 | |
| LNESKCFIKDNTLAL | 221 | Q86UW6 |